Detalhe da pesquisa
1.
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
PLoS Pathog
; 16(12): e1009127, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326472
2.
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
J Antimicrob Chemother
; 76(7): 1874-1885, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880524
3.
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759267
4.
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455237
5.
Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages.
Front Cell Infect Microbiol
; 13: 1067285, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875528
6.
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.
Nat Commun
; 14(1): 199, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639383
7.
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
Viruses
; 14(7)2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891437
8.
VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.
J Leukoc Biol
; 111(5): 1107-1121, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322471
9.
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts.
Front Immunol
; 13: 820131, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251001
10.
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
Viruses
; 14(2)2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35215969
11.
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo.
Pharmaceuticals (Basel)
; 15(1)2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35056078
12.
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
Cell Death Discov
; 7(1): 43, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649297
13.
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
PLoS Negl Trop Dis
; 13(1): e0007072, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30699122
14.
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae.
Sci Rep
; 7(1): 9409, 2017 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842610
15.
Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
Cell Death Discov
; 7(1): 116, 2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011951
16.
Massive Submandibular Sialolith: Complete Radiographic Registration and Biochemical Analysis through X-Ray Diffraction.
Case Rep Surg
; 2014: 659270, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25258693